{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:50:04Z","timestamp":1778028604209,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T00:00:00Z","timestamp":1110499200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s00415-005-0774-3","type":"journal-article","created":{"date-parts":[[2005,3,10]],"date-time":"2005-03-10T14:39:32Z","timestamp":1110465572000},"page":"904-907","source":"Crossref","is-referenced-by-count":54,"title":["Botulinum toxin type B de novo therapy of cervical dystonia"],"prefix":"10.1007","volume":"252","author":[{"given":"D.","family":"Dressler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Bigalke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,3,11]]},"reference":[{"key":"774_CR1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1017\/S031716710003540X","volume":"12","author":"Tsui","year":"1985","unstructured":"Tsui JK, Eisen A, Mak E, Carruthers J, Scott A, Calne (1985) DBA pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sci 12:314\u2013316","journal-title":"Can J Neurol Sci"},{"key":"774_CR2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/archneur.1991.00530240057020","volume":"48","author":"Jankovic","year":"1991","unstructured":"Jankovic J, Schwartz KS (1991) Clinical correlates of response to botulinum toxin injections. Arch Neurol 48:1253\u20131256","journal-title":"Arch Neurol"},{"key":"774_CR3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00007611-199205000-00013","volume":"85","author":"Anderson","year":"1992","unstructured":"Anderson TJ, Rivest J, Stell R, Steiger MJ, Cohen H, Thompson PD, Marsden CD (1992) Botulinum toxin treatment of spasmodic torticollis. J R Soc Med 85:524\u2013529","journal-title":"J R Soc Med"},{"key":"774_CR4","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1212\/WNL.43.9.1715","volume":"43","author":"Zuber","year":"1993","unstructured":"Zuber M, Sebald M, Bathien N, de Recondo J, Rondot P (1993) Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance. Neurology 43:1715\u20131718","journal-title":"Neurology"},{"key":"774_CR5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mds.870110211","volume":"11","author":"Greene","year":"1994","unstructured":"Greene PE, Fahn S (1994) Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients. Mov Disord 11:181\u2013184","journal-title":"Mov Disord"},{"key":"774_CR6","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1212\/WNL.45.9.1743","volume":"45","author":"Jankovic","year":"1995","unstructured":"Jankovic J, Schwartz K (1995) Response and immunoresistance to botulinum toxin injections. Neurology 45:1743\u20131746","journal-title":"Neurology"},{"key":"774_CR7","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s004150070132","volume":"247","author":"Dressler","year":"2000","unstructured":"Dressler D, Rothwell JC, Bigalke H (2000) The sternocleidomastoid test: an in-vivo assay to investigate botulinum toxin antibody formation in man. J Neurol 247:630\u2013632","journal-title":"J Neurol"},{"key":"774_CR8","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.53.7.1439","volume":"53","author":"Brashear","year":"1999","unstructured":"Brashear A, Lew MF, Dykstra DD, Comella CL, Factor SA, Rodnitzky RL, Trosch R, Singer C, Brin MF, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M (1999) Safety and efficacy of Neuro- Bloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 53:1439\u20131446","journal-title":"Neurology"},{"key":"774_CR9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00415-003-1129-6","volume":"250","author":"Dressler","year":"2003","unstructured":"Dressler D, Benecke R, Bigalke H (2003) Botulinum toxin type B (Neuro- Bloc\u00ae in patients with botulinum toxin type A antibody-induced therapy failure. J Neurol 250:967\u2013969","journal-title":"J Neurol"},{"key":"774_CR10","first-page":"445","volume":"40","author":"Consky","year":"1990","unstructured":"Consky ES, Basinski A, Belle L, Ranawaya R, Lang AE (1990) The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS): assessment of validity and inter-rater reliability. Neurology 40(Suppl 1):445","journal-title":"Neurology"},{"key":"774_CR11","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1002\/mds.20022","volume":"19","author":"Dressler","year":"2004","unstructured":"Dressler D, Lange M, Bigalke H (2004) Detecting neutralising antibodies against botulinum toxin type B with a mouse diaphragm assay. Mov Disord 19(Suppl 9:S105","journal-title":"Mov Disord"},{"key":"774_CR12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/exnr.1997.6580","volume":"147","author":"Goschel","year":"1997","unstructured":"Goschel H, Wohlfarth K, Frevert J, Dengler R, Bigalke H (1997) Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies\u2013therapeutic consequences. Exp Neurol 147:96\u2013102","journal-title":"Exp Neurol"},{"key":"774_CR13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000067023","volume":"49","author":"Dressler","year":"2003","unstructured":"Dressler D, Benecke R (2003) Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur Neurol 49: 34\u201338","journal-title":"Eur Neurol"},{"key":"774_CR14","first-page":"S67","volume":"4","author":"Dressler","year":"1997","unstructured":"Dressler D (1997) Botulinum toxin therapy failure: causes, evaluation procedures and management strategies. Eur J Neurol 4(Suppl 2):S67\u2013S70","journal-title":"Eur J Neurol"},{"key":"774_CR15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s004150050345","volume":"246","author":"Kessler","year":"1999","unstructured":"Kessler KR, Skutta M, Benecke R (1999) Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group. J Neurol 246:265\u2013274","journal-title":"J Neurol"},{"key":"774_CR16","first-page":"R25","volume":"365","author":"Jankovic","year":"2002","unstructured":"Jankovic J, Ahsan J, Vuong KD (2002) Comparison of immunogenicity of old versus current BOTOX in cervical dystonia. Naunyn Schmiedebergs Arch Pharmacol 365(Suppl 2):R25","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"774_CR17","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1212\/WNL.55.10.22A","volume":"55","author":"Setler","year":"2000","unstructured":"Setler P (2000) The biochemistry of botulinum toxin type B. Neurology 55(Suppl 5):S22\u2013S28","journal-title":"Neurology"},{"key":"774_CR18","unstructured":"Health and Human Services, Public Health Service, Food and Drug Administration, Center for Biologics Evaluation and Research, Division of Clinical Trial Design and Analysis (2000) Myo- Bloc: Summary Basis of Approval Cervical Dystonia. Supplemental Clinical Review. Available from US Government through Freedom of Information (http:\/\/www. fda. gov\/cder\/biologics\/pr oducts\/botelan12800. htm)"},{"key":"774_CR19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s004150070100","volume":"247","author":"Dressler","year":"2000","unstructured":"Dressler D (2000) Complete secondary botulinum toxin therapy failure in blepharospasm. J Neurol 247:809\u2013810","journal-title":"J Neurol"},{"key":"774_CR20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00415-004-0347-x","volume":"251","author":"Dressler","year":"2004","unstructured":"Dressler D (2004) New formulation of BOTOX\u00ae: Complete antibody-induced therapy failure in hemifacial spasm. J Neurol 251:360","journal-title":"J Neurol"},{"key":"774_CR21","first-page":"51","volume":"15","author":"Dressler","year":"2000","unstructured":"Dressler D, Dirnberger G (2000) Botulinum toxin therapy: Risk factors for therapy failure. Mov Disord 15(Suppl 2):51","journal-title":"Mov Disord"},{"key":"774_CR22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000064953","volume":"48","author":"Dressler","year":"2002","unstructured":"Dressler D (2002) Clinical features of secondary failure of botulinum toxin therapy. Eur Neurol 48:26\u201329","journal-title":"Eur Neurol"},{"key":"774_CR23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000047963","volume":"47","author":"Dressler","year":"2002","unstructured":"Dressler D, Muenchau A, Bhatia KP, Quinn NP, Bigalke H (2002) Antibody induced botulinum toxin therapy failure: Can it be overcome by increased botulinum toxin doses? Eur Neurol 47: 118\u2013121","journal-title":"Eur Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-0774-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-005-0774-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-0774-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:03:59Z","timestamp":1559070239000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-005-0774-3"}},"subtitle":["Frequency of antibody induced therapy failure"],"short-title":[],"issued":{"date-parts":[[2005,3,11]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["774"],"URL":"https:\/\/doi.org\/10.1007\/s00415-005-0774-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,11]]}}}